MedTrace Logo

HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION

NCT02799771 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2022-08-03

No results posted yet for this study

Summary

HYPID-2 study is an extension of HYPID study (NCT01443598) :

HYPID-2 is also an observational and prospective study of patients with interstitial lung disease and pre capillary hypertension diagnosed by right heart sided catheterization.

It concerns only incident patients (i.e patients included within 6 months after PH diagnosis) whereas HYPID concerned prevalent and incident cases.

The primary aim is the same than HYPID : identify prognostic factors

Conditions

Sponsors & Collaborators

  • Hospices Civils de Lyon

    collaborator OTHER

  • Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires

    lead OTHER

Principal Investigators

  • Vincent COTTIN, MD · Hospices civils de Lyon / Université Lyon I

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2018-02-28
Completion
2022-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02799771 on ClinicalTrials.gov